The HepaRG-Bio-Artificial Liver: Feasibility of commercialization and expansion of business plan

Project Information

BALXPAND

Grant agreement ID: 763310

DOI 10.3030/763310

Project closed

EC signature date 4 February 2017

Start date 1 March 2017

End date 31 August 2017

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

HEP-ART MEDICAL DEVICES BV
Netherlands